| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.39 | 0.007 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.44 | 0.009 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |